USPS® – The Market-leading technology
Our newest development – the proprietary Ultra Sonic Peptide Synthesis (USPS®) platform – enables us to produce peptides at an unprecedented speed: We manufacture hundreds of peptides within hours.
By developing our peptide synthesis robots in-house, we have full control over the manufacturing process. This means we can assure high quality at budget-friendly prices and respond quickly and flexibly to all research requirements.
USPS® supplies a wide range of research projects with high-quality peptides, particularly in the field of Immunology.
Examples are research projects for
- discovery of new drugs
- development of novel therapies and vaccines
- establishment of new diagnostic and analytical methods
- fundamental research.
USPS® allows a wider application of personalized cancer therapeutics. By synthesizing large numbers of individual peptides in a short period of time, it is possible to produce sufficient personalized peptide cancer vaccines to treat an unlimited number of patients.
Within 2021, peptides & elephants completed development of the prototype USPS® synthesizer, in accordance with all GMP regulations. Since 2022 the technology is fully implemented in the production line. All steps in product manufacturing, from order acceptance to synthesis, processing, quality control and pharmaceutical packaging, are managed by one system that works according to Industry 4.0 standards ensuring highest quality and safety. The entire process is ISO 9001:2025 certified.